A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE ESCALATION STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF A SUBCUTANEOUS DOSE OF SHK-186 IN HEALTHY SUBJECTS - ShK-186 SAD study
100 Clinical Results associated with Kineta One LLC
0 Patents (Medical) associated with Kineta One LLC
100 Deals associated with Kineta One LLC
100 Translational Medicine associated with Kineta One LLC